SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

25.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 25.83
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 231.98m
  • Volume: 362,194
  • Market Cap: £57.99m
  • Beta: 0.02

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 25.00p
Change Today 0.50p
% Change 2.04 %
52 Week High 25.83
52 Week Low 8.50
Volume 362,194
Shares Issued 231.98m
Market Cap £57.99m
Beta 0.02

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.96% below the market average70.96% below the market average70.96% below the market average70.96% below the market average70.96% below the market average
95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average95.83% below the sector average
Price Trend
93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average93.80% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
47.52% above the market average47.52% above the market average47.52% above the market average47.52% above the market average47.52% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

SBTX Dividends

No dividends found

Trades for 02-Apr-2025

Time Volume / Share Price
10:38 25,000 @ 25.05p
10:37 3,173 @ 25.05p
10:37 80,000 @ 25.11p
10:36 3,888 @ 25.59p
10:31 11,656 @ 25.65p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page